Document is current
Any future updates will be listed below
-
Authors
Beckman, Kenneth A.
Parkhurst, Gregory D.
Lee, James H.
Al-Mohtaseb, Zaina N.
Greenwood, Michael D.
Armijo, Marco
Smith, Valerie
Leone, Erin H.
Kothe, Angela C. https://orcid.org/0009-0000-7971-5292
Navratil, Tomas https://orcid.org/0009-0007-3577-3096
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05759559 at ClinicalTrials.govDocuments that mention this clinical trial
Randomized, Controlled Study to Evaluate the Safety and Efficacy of Oxygen-Enriched Epithelium-On Corneal Cross-Linking for the Treatment of Keratoconus
https://doi.org/10.1007/s40123-026-01364-7
- License Information
-
More Information
Article History
Received: 4 February 2026
Accepted: 3 March 2026
First Online: 13 March 2026
Declarations
:
: The authors have made the following disclosures: Kenneth A. Beckman received financial and nonfinancial support from Glaukos, is a lecturer for Glaukos and is on the advisory board for Glaukos. Gregory D. Parkhurst and James H. Lee received financial support from Glaukos. Zaina N. Al-Mohtaseb is a consultant and lecturer for Glaukos. Michael D. Greenwood received financial and nonfinancial support from Glaukos, and is a consultant and lecturer for Glaukos. Marco Armijo, Valerie Smith, Erin H. Leone, Angela C. Kothe and Tomas Navratil are employees of Glaukos Corporation and may own stock and/or stock options.
: The study was conducted in accordance with US regulations and the International Council for Harmonisation Guidelines on Good Clinical Practice which embody the tenets of the Declaration of Helsinki of 1964 and its later amendments. Institutional review board (IRB) approval (Alpha IRB, San Clemente, CA; GLK-202-02; approval date 12 December 2022) was obtained for the study. All patients provided written informed consent prior to their participation. Furthermore, those who were under the age of 18 years (or had not yet reached the age of majority per local regulations) signed the most recent IRB-approved assent form, and their parent or legal guardian signed the most recent IRB-approved informed consent form.
